1991
DOI: 10.1055/s-0038-1647457
|View full text |Cite
|
Sign up to set email alerts
|

Antithrombotic Mechanisms of Urokinase lmmobilized Polyurethane

Abstract: SummaryUrokinase immobilized polymer is highly antithrombotic, which cannot be explained only by fibrinolysis. We immobllized 10 IU/cm2 of urokinase to polyurethane by using maleic anhydride methylvinyl ether copolymer as a carrier. Then we incubated blood in circular tubes made of this material, measured the clotting factors and observed the surface of the tubes after incubation by scanning electronmicroscopy and immunofluorescence microscopy. After 5 min incubation, the relative activities of factors V, VIII… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 6 publications
0
16
0
Order By: Relevance
“…Other important factors, which play a role in graft patency maintenance, are fibrinolysis system components [18,[20][21][22]25,33]. Our results demonstrated increasing intensity of t-PA and u-PA expression with the time following prosthesis implantation.…”
Section: Article In Pressmentioning
confidence: 45%
See 1 more Smart Citation
“…Other important factors, which play a role in graft patency maintenance, are fibrinolysis system components [18,[20][21][22]25,33]. Our results demonstrated increasing intensity of t-PA and u-PA expression with the time following prosthesis implantation.…”
Section: Article In Pressmentioning
confidence: 45%
“…Furthermore it is significantly higher than in the corresponding layer of arteries [5,18] and its impairment may contribute to early graft thrombosis [19]. Plasminogen activators increase fibrinolytic potential of the biomaterial luminal surface and predispose to graft patency maintenance [20][21][22]. Whereas the graft failure is associated wit an up-regulation of PAI-1, which results in reduced total fibrinolytic potential of the graft [23][24][25].…”
Section: Introductionmentioning
confidence: 99%
“…However, graft thrombosis is still a serious clinical problem in spite of continuous improvements in graft development [14]. Polyurethane has been used to solve the thrombus problem due to its excellent elasticity and biocompatibility, and a microporous structure can be successfully fabricated in the wall using different methods [15][16][17][18][19][20][21][22]. The porosity of commercially available polyester (Dacron) knitted vascular grafts can be reduced by coating or sealing with a novel ionic urethane, to improve their blood-proof property.…”
Section: Introductionmentioning
confidence: 99%
“…However, graft thrombosis is still a serious clinical problem in spite of continuous improvements in grafts and vascular surgery 14. Polyurethane appears to be a satisfactory material to solve the thrombus problem due to its excellent elastic property and the biocompatibility, microporous structure can be successfully fabricated in the wall of the vascular grafts using different methods 15–22. Porosity in the vascular grafts wall can be reduced by coating or sealing with a novel ionic urethane, to improve their blood leakproof property.…”
Section: Introductionmentioning
confidence: 99%